Abstract
The article provides an analysis of the data of the state cancer registry on the registration and treatment of patients with prostate cancer (PC) for the period 2009–2020. Based on the analysis of the registry data, a method was proposed to identify a subgroup of patients with indirect signs of non-metastatic castration-resistant prostate cancer (nmCRPC), for which the risk of developing distant metastases was analyzed. The article presents data on the prevalence of nmCRPC n 2018–2020 among the contingent of patients registered with prostate cancer in Russia, in comparison with global and Russian data on the study of the epidemiology and natural course of nmCRPC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
